These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


468 related items for PubMed ID: 8607151

  • 1. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
    Busch MP, Kleinman SH, Williams AE, Smith JW, Ownby HE, Laycock ME, Lee LL, Pau CP, Schreiber GB.
    Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151
    [Abstract] [Full Text] [Related]

  • 2. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.
    Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR.
    Transfusion; 1995 Feb; 35(2):91-7. PubMed ID: 7825218
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot.
    Jackson JB, Hanson MR, Johnson GM, Spahlinger TG, Polesky HF, Bowman RJ.
    Transfusion; 1995 Feb; 35(2):98-102. PubMed ID: 7825219
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of epidemiological and serological predictors of human immunodeficiency virus type-1 (HIV-1) infection among high risk professional blood donors with western blot indeterminate results.
    Chattopadhya D, Aggarwal RK, Baveja UK, Doda V, Kumari S.
    J Clin Virol; 1998 Jul 24; 11(1):39-49. PubMed ID: 9784142
    [Abstract] [Full Text] [Related]

  • 5. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study.
    Kleinman S, Busch MP, Hall L, Thomson R, Glynn S, Gallahan D, Ownby HE, Williams AE.
    JAMA; 1998 Jul 24; 280(12):1080-5. PubMed ID: 9757856
    [Abstract] [Full Text] [Related]

  • 6. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
    Tobler LH, Kaufman E, Gefter N, Schable C, Busch MP.
    Transfusion; 1997 Sep 24; 37(9):921-5. PubMed ID: 9308638
    [Abstract] [Full Text] [Related]

  • 7. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors.
    Sayre KR, Dodd RY, Tegtmeier G, Layug L, Alexander SS, Busch MP.
    Transfusion; 1996 Jan 24; 36(1):45-52. PubMed ID: 8607152
    [Abstract] [Full Text] [Related]

  • 8. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
    Busch MP, el Amad Z, McHugh TM, Chien D, Polito AJ.
    Transfusion; 1991 Feb 24; 31(2):129-37. PubMed ID: 1899951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monitoring blood donors for HIV-2 infection by testing anti-HIV-1 reactive sera.
    Busch MP, Petersen L, Schable C, Perkins H.
    Transfusion; 1990 Feb 24; 30(2):184-7. PubMed ID: 1968296
    [Abstract] [Full Text] [Related]

  • 11. [Follow-up of blood donors with indeterminate reaction to anti-HIV 1/2 EIA or isolated detection of antibodies to HIV-1 core antigens (anti-p24)].
    Zimmermann R, Zeiler T, Zingsem J, Weisbach V, Müller C, Huhn D, Eckstein R.
    Beitr Infusionsther; 1992 Feb 24; 30():82-4. PubMed ID: 1284775
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Longitudinal follow-up of blood donors found to be reactive for antibody to human immunodeficiency virus (anti-HIV) by enzyme-linked immunoassay (EIA+) but negative by western blot (WB-).
    Nusbacher J, Naiman R.
    Transfusion; 1989 May 24; 29(4):365-7. PubMed ID: 2655209
    [Abstract] [Full Text] [Related]

  • 14. What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors?
    Genesca J, Shih JW, Jett BW, Hewlett IK, Epstein JS, Alter HJ.
    Lancet; 1989 Oct 28; 2(8670):1023-5. PubMed ID: 2572749
    [Abstract] [Full Text] [Related]

  • 15. The significance of HIV-1-indeterminate western blot results in blood donor populations.
    Kleinman S.
    Arch Pathol Lab Med; 1990 Mar 28; 114(3):298-303. PubMed ID: 2154962
    [Abstract] [Full Text] [Related]

  • 16. Screening for human immunodeficiency virus type 1 and 2 in a Turkish blood donor population.
    Altuglu I, Sayiner AA, Erensoy S, Zeytinoglu A, Bilgiç A.
    Int J Infect Dis; 1998 Mar 28; 2(4):202-4. PubMed ID: 9763502
    [Abstract] [Full Text] [Related]

  • 17. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay.
    Gürtler L, Mühlbacher A, Michl U, Hofmann H, Paggi GG, Bossi V, Thorstensson R, G-Villaescusa R, Eiras A, Hernandez JM, Melchior W, Donie F, Weber B.
    J Virol Methods; 1998 Nov 28; 75(1):27-38. PubMed ID: 9820572
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Indeterminate human immunodeficiency virus type 1 western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation.
    Celum CL, Coombs RW, Lafferty W, Inui TS, Louie PH, Gates CA, McCreedy BJ, Egan R, Grove T, Alexander S.
    J Infect Dis; 1991 Oct 28; 164(4):656-64. PubMed ID: 1894929
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns.
    Ayisi NK, Aidoo M.
    West Afr J Med; 1994 Oct 28; 13(3):164-7. PubMed ID: 7841107
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.